Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Followed by DICEP in NK/T-cell Lymphoma
NCT01667302Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jun 2012
- Primary completion
- Dec 2013
- Modality
- Therapeutic Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase, dexamethasone, ifosfamide, etoposide, cisplatin in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT), sponsored by Fudan University. Status: unknown.
02
Drugs
pegaspargasedexamethasoneifosfamideetoposidecisplatin
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT01667302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667302.